FDA Grants Priority Review for New Drug Application of Narcolepsy Investigational Compound Pitolisant - Sleep Review https://t.co/bMqJVaVava — IDRO (@IDROOhio) February 14, 2019
FDA Grants Priority Review for New Drug Application of Narcolepsy Investigational Compound Pitolisant - Sleep Review https://t.co/bMqJVaVava
No comments:
Post a Comment